首頁 > 市場調查報告書 > 材料

塑膠

市場調查報告書

商品編碼

1634239

全球發泡錠市場 - 2024 - 2031

Global Effervescent Tablet Market - 2024 - 2031

出版日期: 2025年01月13日 | 出版商:

DataM Intelligence | 英文 159 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2023年，全球發泡錠市場規模達99.8億美元，預估至2031年將達201.3億美元，2024-2031年預測期間複合年成長率為9.17%。

發泡錠是透過壓制由檸檬酸和碳酸氫鈉組成的泡騰顆粒而製成的。當這些藥片浸入水中時，酸和鹼之間的反應產生二氧化碳，在液體中表現為氣泡。這些片劑的快速崩解有助於快速溶解和吸收。

發泡錠的市佔率受到多個變數的影響，這些變數增強了發泡錠在眾多領域的吸引力和擴張，包括便利性、膳食補充劑需求增加、藥品用途和不斷成長的非處方藥市場。過量服用某些發泡錠可能會導致有害影響而不是治療效果，從而限制市場擴張。由於各種驅動力，該行業正在經歷大幅擴張。

發泡錠在老年人中的普及率不斷上升是一項重大發展，因為這些片劑為行動不便或吞嚥固體形式有困難的個人提供了方便和促進攝入。青少年和兒童泡騰補充劑的激增正在擴大市場範圍，使其成為許多年齡層的多功能選擇。與可能需要延長消化時間的傳統藥物相比，泡騰減肥補充劑可以更快發揮作用，從而促進體重控制工作更快取得成果。

動力學

促進因素 1 - 對膳食補充劑的需求不斷成長

隨著消費者越來越追求簡單、愉快和有效的方法來改善他們的健康和保健，對營養補充劑的需求不斷成長，極大地推動了發泡錠市場的發展。發泡錠可快速吸收並促進消化，使其成為注重健康人士的首選。

對維生素、礦物質和草藥補充劑的需求不斷成長，尤其是千禧世代和健康愛好者，促使製造商開發和擴大其泡騰產品系列。此外，泡騰製劑的吸引力通常與增強風味和愉悅的消費體驗有關，這與消費者對能夠輕鬆融入生活方式的功能性產品的傾向相一致，從而推動了該領域的成長。

維生素C是公認的膳食維生素，具有增強免疫力的特性。維生素C發泡錠因其口感好、服用方便而受到消費者的歡迎。維生素 C 發泡錠比傳統維生素 C 片或膠囊更受歡迎，因為它們能夠溶解在水中，形成可口的泡騰飲料。多種維生素是公認的營養補充劑，含有多種維生素和礦物質。

多種維生素發泡錠提供全面的解決方案，以方便、愉快的方式滿足日常營養需求。負責任營養委員會的膳食補充劑年度調查表明，美國膳食補充劑的使用量已達到歷史最高水準。民調顯示，76% 的美國人會使用膳食補充劑，比去年的 74% 增加。這些資料顯示人們對膳食補充劑的興趣和依賴日益增加，以增強整體健康和保健。這推動了發泡錠產業的擴張。

促進因素 2 - 提高病患依從性和治療效率

發泡錠提高患者依從性的能力是一個重要因素，尤其是難以吞嚥傳統片劑的患者，包括老年人、兒童和吞嚥困難患者。這種新穎的配方將藥物轉化為美味且易於攝取的液體，滿足了醫療保健領域未滿足的重大需求。

泡騰技術除了簡單的管理之外還具有多種優點。發泡錠透過添加大量活性藥物成分 (API) 來提高溶解度和生物利用度，從而加快治療效果並減少胃腸道刺激。由水環境中酸鹼反應驅動的快速溶解過程說明了它們在給藥方面的功效。這些特性使得發泡錠特別適用於疏水性或在某些 pH 條件下不穩定的活性藥物成分，從而將其用途擴展到不同的治療領域。

最近的創新增強了發泡錠的適應性。創新包括胃滯留和緩釋製劑，促進有針對性的藥物分佈，延長在胃腸道的停留時間並最大限度地減少給藥頻率。這不僅改善了治療效果，也減少了不良反應，從而提高了患者的依從性。

限制因素：生產成本高

由於對複雜生產技術和特定包裝的要求，發泡錠的生產要求很高。這些藥丸極易受潮，需要低濕度和密封包裝的規範生產條件以確保穩定性。優質輔料和複雜配方的使用增加了生產成本。 FDA 和 EMA 等監管機構實施嚴格的品質標準，以確保泡騰產品的安全性和有效性，特別是在藥品和膳食補充劑領域。

製造商必須遵守良好生產規範 (GMP) 並執行嚴格的測試來滿足這些標準，從而提高營運成本。過高的費用可能會導致零售價格上漲，從而限制價格敏感市場的可及性。這種經濟障礙限制了消費者的採用並阻礙了市場滲透，特別是在新興領域，因此成為市場擴張的重大限制。

Effervescent tablets are manufactured by compressing effervescent granules composed of citric acid and sodium bicarbonate. When these tablets are immersed in water, the reaction between the acid and the base generates carbon dioxide, manifesting as gas bubbles in the liquid. The rapid disintegration of these tablets facilitates swift dissolving and absorption.

The market share of effervescent tablets is influenced by multiple variables that enhance their appeal and expansion across numerous sectors, including convenience, heightened demand for dietary supplements, pharmaceutical uses and the growing over-the-counter market. Excessive consumption of certain effervescent pills can lead to detrimental effects instead of therapeutic benefits, hence constraining market expansion. The industry is undergoing substantial expansion owing to various driving forces.

The rising prevalence of effervescent tablets among the elderly is a significant development, as these tablets provide convenience and facilitate intake for individuals with mobility challenges or difficulties in swallowing solid forms. The proliferation of effervescent supplements for youth and children is broadening the market's scope, rendering it a versatile option for many age demographics. In contrast to traditional drugs that may require extended digestion time, effervescent weight reduction supplements provide a more rapid commencement of action, hence promoting swifter outcomes in weight control endeavors.

Dynamics

Driver 1 - Growing Demand for Dietary Supplements

The rising demand for nutritional supplements is substantially propelling the effervescent tablet market as customers increasingly pursue easy, pleasant and efficacious methods to improve their health and wellness. Effervescent tablets provide rapid absorption and facilitate digestion, rendering them a favored option for health-conscious persons.

The increasing demand for vitamins, minerals and herbal supplements, especially among millennials and health aficionados, has prompted manufacturers to develop and broaden their effervescent product offerings. Moreover, the allure of effervescent formulations, frequently linked to enhanced flavor and pleasurable consumption experiences, corresponds with consumer inclinations for functional items that integrate effortlessly into their lifestyles, thereby propelling growth in this sector.

Vitamin C is a recognized dietary vitamin possessing immune-enhancing properties. Effervescent vitamin C tablets have gained popularity among customers due to their agreeable taste and convenient administration. Effervescent vitamin C tablets are favored over conventional vitamin C tablets or capsules due to their ability to dissolve in water, creating a palatable and effervescent beverage. Multivitamins are recognized nutritional supplements containing an assortment of vitamins and minerals.

Effervescent multivitamin tablets offer a comprehensive solution for fulfilling daily nutritional requirements in a convenient and enjoyable manner. The Council for Responsible Nutrition's Annual Survey on Dietary Supplements indicates that dietary supplement utilization in the US has reached a record peak. The poll indicates that 76% of individuals in the US will utilize dietary supplements, an increase from 74% the prior year. This data illustrates the increasing interest in and reliance on dietary supplements to enhance overall health and wellness. This propels the expansion of the effervescent tablet industry.

Driver 2 - Advancing Patient Compliance and Therapeutic Efficiency

The ability of effervescent tablets to enhance patient compliance, especially in patients who struggle to swallow traditional tablets, including the elderly, children and those with dysphagia, is a significant factor. This novel formulation converts medication into a tasty and easily ingestible fluid, fulfilling a significant unmet need in healthcare.

Effervescence technology has various advantages beyond simple administration. Effervescent tablets boost solubility and bioavailability by adding substantial quantities of Active Pharmaceutical Ingredients (APIs), resulting in expedited therapeutic effects with reduced gastrointestinal irritation. The fast dissolution process, driven by an acid-base reaction in an aqueous environment, illustrates their efficacy in drug administration. The characteristics render effervescent tablets especially appropriate for active pharmaceutical ingredients that are hydrophobic or unstable in certain pH conditions, thus expanding their utility across diverse therapeutic domains.

Recent innovations have enhanced the adaptability of effervescent pills. Innovations include gastro-retentive and slow-release formulations facilitate targeted medication distribution, extending residence duration in the gastrointestinal tract and minimizing dose frequency. This not only improves therapeutic results but also reduces adverse effects, hence increasing patient compliance.

Restraint: High Production Costs

The manufacturing of effervescent tablets is high due to the requirement for sophisticated production techniques and specific packaging. These pills are extremely susceptible to moisture, requiring regulated production conditions with low humidity and sealed packaging to ensure stability. The utilization of premium excipients and sophisticated formulations increases production expenses. Regulatory bodies like the FDA and EMA impose rigorous quality standards to guarantee the safety and efficacy of effervescent products, particularly in pharmaceutical and dietary supplement contexts.

Manufacturers must comply with Good Manufacturing Practices (GMP) and perform stringent testing to fulfill these standards, hence elevating operational costs. Exorbitant expenses can result in increased retail pricing, constraining accessibility in price-sensitive markets. This economic obstacle limits consumer adoption and impedes market penetration, especially in emerging areas, therefore serving as a substantial constraint on market expansion.

Segment Analysis

The global effervescent tablet market is segmented based on product type, form, packaging type, type, application, distribution channel and region.

Rising Enhanced Packaging

Aluminum and plastic tubes signify a notable improvement in packaging solutions for effervescent tablets, effectively mitigating essential issues related to moisture exposure that can negatively impact product quality. In the nutritional supplement sector, moisture can infiltrate packaging, resulting in early breakdown, color degradation, diminished efficacy or the emergence of unpleasant odors in effervescent pills.

In addition to moisture protection, the packaging design of aluminum and plastic tubes markedly improves brand visibility and consumer recognition at the point of sale. The potential for photorealistic printing enables firms to produce visually striking packaging that distinguishes itself in a saturated market.

Diverse surface textures, removable labels and cost-effective CMYK printing with a maximum of eight colors, inclusive of metallic finishes, empower businesses to convey vital product information in an appealing and clear manner. This focus on visual appeal, coupled with effective branding methods, corresponds with the growing consumer inclination towards health-oriented products, hence enhancing brand loyalty and consumer engagement.

The utilization of low-migration paints and varnishes that conform to international food safety standards highlights a dedication to safety and compliance in the packaging of effervescent tablets. By using for aluminium or plastic tubes for packaging, producers may safeguard their effervescent products from environmental influences while maintaining a professional and aesthetically pleasing presentation.

Geographical Penetration

Rising prevalence of chronic diseases in North America

The rising prevalence of chronic diseases and the presence of significant market players are ascribed to regional expansion. CDC statistics indicates that in 2020, there were 1,603,844 newly reported cancer cases in the US, along with 602,347 documented cancer-related deaths. For every 100,000 individuals, there were 403 newly diagnosed instances of cancer and 144 cancer-related fatalities. The FDA oversees dietary supplements and medications.

Dietary supplements, particularly effervescent tablets, are required to comply with FDA requirements. The FDA regulations safeguard product safety and quality, influencing market access and growth in North America. Moreover, the region's growing senior demographic and novel product launches propel market revenue.

Competitive Landscape

The major players in the market include Pfizer Inc., Novartis AG, Perrigo Company plc, Bristol-Myers Squibb Company, CHIESI SAS, Hermes Pharma, Herbalife International of America, Inc., Vovantis Laboratories, Natur Produkt Zdrovit Sp Z O O and Amerilab Technologies Inc.

Sustainability Analysis

The sustainability of the effervescent tablet market is supported by its environmentally friendly characteristics and its conformity with changing consumer and industry trends. Effervescent tablets, especially in cleaning applications, are biodegradable and eco-friendly, leaving no detrimental residues in ecosystems. Their compact, concentrated formulations diminish the necessity for unnecessary product application, therefore reducing waste and resource usage. This efficiency aligns with consumer aspirations for sustainable and economical cleaning solutions.

Innovations in packaging enhance the market's sustainability. Effervescent pills advantageously utilize the increasing transition towards bio-based and biodegradable packaging. Traditionally, the plastics sector depended significantly on fossil-derived materials; however, recent innovations have resulted in a greater utilization of renewable resources in packaging. Bio-based plastics, present in various forms since the 19th century, are seeing a resurgence, providing feasible solutions for mitigating the environmental impact of packaging.

Effervescent products also address the trend of minimizing packaging via e-commerce and subscription-based distribution models. These strategies correspond with consumer initiatives to reduce their ecological impact while maintaining convenience. The variety of effervescent tablets, which includes applications from denture cleaners to household cleaning agents, enhances their market appeal and emphasizes their contribution to sustainable consumption practices.

Consumer Behaviour Analysis

Consumer behavior regarding effervescent tablets indicates an increasing demand for alternative supplement delivery methods, as demonstrated by the surge in non-pill supplements, which currently represent approximately 34% of US supplement sales. The change is driven by consumers' inclination towards pleasurable and convenient alternatives, with formats like as candies, drink mixes and effervescent tablets becoming more favored than conventional pills. Gummy supplements have attained an impressive growth in recent years, underscoring the desire for formats that integrate functionality with an enjoyable experience.

Effervescent tablets provide a unique benefit by delivering nutrients in a palatable, carbonated beverage, attracting consumers who value flavor and convenience. These traits correspond with trends noted in other formats, where 52% of gummy consumers identify taste as the paramount characteristic, above affordability (37%) and high-quality components (25%). Effervescent pills address the demand for convenient, portable solutions that may be used without water, appealing to busy, health-conscious persons.

The increasing focus on clean-label supplements, propelled by Millennials and Gen Z, enhances the attractiveness of effervescent tablets. Consumers are progressively pursuing products containing natural ingredients, devoid of preservatives and artificial additives, hence affirming the appeal of effervescent tablets in the dynamic supplement industry.

Early Stage Innovations

Effervescent tablet formulations indicate an emerging invention with potential uses in sustained and gastro-retentive medication delivery systems. Recent developments underscore their promise in tackling critical obstacles including quick medication onset, restricted bioavailability and frequent dosage necessities. Effervescent tablets of nateglinide exhibited 99% drug release after 24 hours and maintained stability under diverse environmental conditions, addressing the limited duration of insulinotropic activity in the treatment of type II diabetes mellitus. The tablets, formulated using direct compression, employed excipients such as ethyl cellulose and Carbopol 930, with compatibility verified by FTIR and DSC analyses.

Effervescent floating tablets of fluoxetine for the treatment of depression demonstrated a 96% release within 12 hours, conforming to the Korsmeyer-Peppas release model. Their reliability is emphasized by stability under temperature and humidity fluctuations, as well as strong rheological qualities. Domperidone tablets exemplify a 98% release over 12 hours, underscoring their ability to improve medication absorption in particular gastrointestinal areas.

Effervescent formulations of silymarin flavonolignans for hepatic disorders demonstrated sustained release (95% over 16 hours), demonstrating zero-order kinetics and strong mechanical characteristics. These advances collectively highlight the potential of effervescent tablets to boost therapeutic results by improving drug delivery efficiency and patient compliance, indicating a disruptive approach in pharmaceutical research.

Emerging Market Players and Strategic Initiatives

Effervescent tablets are experiencing a renewed popularity because of changing customer preferences and innovations in manufacturing methods. Despite being generally regarded as an "old-fashioned" dosage type, their increasing market demand highlights its significance in contemporary healthcare. The global effervescent tablet market, valued at $356.3 million in 2023, is anticipated to expand at a strong CAGR of 6.8%, reaching $570.3 million by 2030. This expansion is propelled by their ease of consumption, better flavor and quick medicinal effects, which correspond with customer demands for convenience and an improved user experience.

New entrants are utilizing advanced manufacturing techniques, like TOPO granulation and unique horizontally aligned granulator technology, to enhance the stability, flavor and cost-effectiveness of effervescent tablets. These innovations facilitate accelerated production cycles, diminished carbon footprints and improved shelf life, especially in adverse climates.

Pharmaceutical companies are now strategically reintroducing effervescent tablets as luxury products, leveraging recent technology advancements. Companies are investigating novel formulations with distinctive active ingredients to address various customer categories, including the elderly and younger populations. In doing so, businesses are both broadening their product ranges and strengthening their market position in a competitive and dynamic environment.

Key Developments

In April 2022, Health Innovations Ltd., a UK-based maker of healthcare supplements, launched a novel EfferShield technology for effervescent pills and powders. This proprietary method has been designed to offer clients easy packaging solutions, including single-use pouches and stick packs.

Why Purchase the Report?

To visualize the global effervescent tablet market segmentation based on product type, form, packaging type, type, application, distribution channel and region, as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of the effervescent tablet market with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.

The global effervescent tablet market report would provide approximately 86 tables, 88 figures and 202 pages.

Target Audience 2024

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Form
3.3. Snippet by Packaging Type
3.4. Snippet by Type
3.5. Snippet by Application
3.6. Snippet by Distribution Channel
3.7. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Growing Demand for Dietary Supplements
  - 4.1.1.2. Advancing Patient Compliance and Therapeutic Efficiency
- 4.1.2. Restraints
  - 4.1.2.1. High Production Costs
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. DMI Opinion

6. By Product Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 6.1.2. Market Attractiveness Index, By Product Type
6.2. Nutritional Supplements*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Pharmaceuticals
6.4. Dietary Products
6.5. Energy Boosters
6.6. Others

7. By Form

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 7.1.2. Market Attractiveness Index, By Form
7.2. Enteric Coated Tablets*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Sublingual Tablets
7.4. Chewable Tablets
7.5. Others

8. By Packaging Type

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
- 8.1.2. Market Attractiveness Index, By Age Group
8.2. Plastic/Aluminium Tubes*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Sachets
8.4. Blister Packaging
8.5. Others

9. By Type

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.1.2. Market Attractiveness Index, By Type
9.2. Prescription*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Over the counter

10. By Application

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.1.2. Market Attractiveness Index, By Application
10.2. Personal Care and Beauty*
- 10.2.1. Introduction
- 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Food and Beverage
10.4. Sports and Fitness
10.5. Marine
10.6. Others

11. By Distribution Channel

11.1. Introduction
- 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 11.1.2. Market Attractiveness Index, By Distribution Channel
11.2. Pharmaceuticals*
- 11.2.1. Introduction
- 11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Supermarkets
11.4. eCommerce
11.5. Others

12. By Region

12.1. Introduction
- 12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 12.1.2. Market Attractiveness Index, By Region
12.2. North America
- 12.2.1. Introduction
- 12.2.2. Key Region-Specific Dynamics
- 12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
- 12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 12.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 12.2.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 12.2.9.1. US
  - 12.2.9.2. Canada
  - 12.2.9.3. Mexico
12.3. Europe
- 12.3.1. Introduction
- 12.3.2. Key Region-Specific Dynamics
- 12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
- 12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 12.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 12.3.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 12.3.9.1. Germany
  - 12.3.9.2. UK
  - 12.3.9.3. France
  - 12.3.9.4. Italy
  - 12.3.9.5. Spain
  - 12.3.9.6. Rest of Europe
12.4. South America
- 12.4.1. Introduction
- 12.4.2. Key Region-Specific Dynamics
- 12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
- 12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 12.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 12.4.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 12.4.9.1. Brazil
  - 12.4.9.2. Argentina
  - 12.4.9.3. Rest of South America
12.5. Asia Pacific
- 12.5.1. Introduction
- 12.5.2. Key Region-Specific Dynamics
- 12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
- 12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 12.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 12.5.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 12.5.9.1. China
  - 12.5.9.2. India
  - 12.5.9.3. Japan
  - 12.5.9.4. Australia
  - 12.5.9.5. Rest of Asia Pacific
12.6. Middle East and Africa
- 12.6.1. Introduction
- 12.6.2. Key Region-Specific Dynamics
- 12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
- 12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 12.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 12.6.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel

13. Competitive Landscape

13.1. Competitive Scenario
13.2. Market Positioning/Share Analysis
13.3. Mergers and Acquisitions Analysis

14. Company Profiles

14.1. Pfizer Inc.*
- 14.1.1. Company Overview
- 14.1.2. Product Portfolio and Description
- 14.1.3. Financial Overview
- 14.1.4. Key Developments
14.2. Novartis AG
14.3. Perrigo Company plc
14.4. Bristol-Myers Squibb Company
14.5. CHIESI SAS
14.6. Hermes Pharma
14.7. Herbalife International of America, Inc.
14.8. Vovantis Laboratories
14.9. Natur Produkt Zdrovit Sp Z O O
14.10. Amerilab Technologies Inc.

LIST NOT EXHAUSTIVE